MicroRNA-203 Induces Apoptosis by Targeting Bmi-1 in YD-38 Oral Cancer Cells.
By: Jae-Sung Kim, Dae Woo Choi, Chun Sung Kim, Sun-Kyoung Yu, Heung-Joong Kim, Dae-San Go, Seul Ah Lee, Sung Min Moon, Su Gwan Kim, Hong Sung Chun, Jeongsun Kim, Jong-Keun Kim, DO Kyung Kim

Oral Biology Research Institute, School of Dentistry, Chosun University, Gwangju, Republic of Korea.
2018-03-26; doi: 10.21873/anticanres.12618
Abstract

Background/aim

MicroRNAs (miRNAs) are closely associated with a number of cellular processes, including cell development, differentiation, proliferation, carcinogenesis, and apoptosis. The aim of the present study was to elucidate the molecular mechanisms underlying the tumor suppressor activity of miRNA-203 (miR-203) in YD-38 human oral cancer cells.

Materials

Polymerase chain reaction analysis, MTT assay, DNA fragmentation assay, fluorescence-activated cell-sorting analysis, gene array, immunoblotting, and luciferase assay were carried out in YD-38 cells.

Results

miR-203 expression was significantly down-regulated in YD-38 cells compared to expression levels in normal human oral keratinocytes. miR-203 decreased the viability of YD-38 cells in a time- and dose-dependent manner. In addition, over-expression of miR-203 significantly increased not only DNA segmentation, but also the apoptotic population of YD-38 cells. These results indicate that miR-203 overexpression induces apoptosis in YD-38 cells. Target gene array analysis revealed that the expression of the polycomb complex protein gene Bmi-1, a representative oncogene, was significantly down-regulated by miR-203 in YD-38 cells. Moreover, both mRNA and protein levels of Bmi-1 were significantly reduced in YD-38 cells transfected with miR-203. These results indicate that Bmi-1 is a target gene of miR-203. A luciferase reporter assay confirmed that miR-203 suppressed Bmi-1 expression by directly targeting the 3'-untranslated region.

Conclusion

miR-203 induces apoptosis in YD-38 cells by directly targeting Bmi-1, which suggests its possible application as an anti-cancer therapeutic.



Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

PMID:29848700






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements